Karuna Therapeutics Inc (KRTX)

Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Steven Paul
Employees:
33 ARCH STREET SUITE 3110 BOSTON MA 02110

Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, primarily focuses on developing novel therapies to address disabling neuropsychiatric conditions characterized by significant unmet medical needs. The company's lead product candidate is KarXT, an oral modulator that is in Phase II clinical trial for the treatment of acute psychosis in patients with schizophrenia, as well as in Phase Ib clinical trial for the treatment of central nervous system disorders, such as cognitive and negative symptoms, Alzheimer's, and pain. It also focuses on developing other muscarinic-targeted drug candidates. Karuna Pharmaceuticals, Inc. has a license agreement with Eli Lilly and Company; and patent license agreement with PureTech Health LLC. The company was formerly known as Karuna Pharmaceuticals, Inc. and changed its name to Karuna Therapeutics, Inc. in March 2019. Karuna Therapeutics, Inc. was founded in 2009 and is headquartered in Boston, Massachusetts. Karuna Therapeutics, Inc. operates as a subsidiary of PureTech Health plc.

Data derived from most recent annual or quarterly report
Market Cap 3.873 Billion Shares Outstanding29.551 Million Avg 30-day Volume 99.693 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-2.15
Price to Revenue31.4986 Debt to Equity0.0 EBITDA-33.382 Million
Price to Book Value2.6665 Operating Margin-358.9646 Enterprise Value217.946 Million
Current Ratio7.516 EPS Growth0.721 Quick Ratio6.953
1 Yr BETA 52-week High/Low 146.97 / 77.85 Profit Margin-363.205
Operating Cash Flow Growth-45.7097 Altman Z-Score13.1882 Free Cash Flow to Firm -55.319 Million
View SEC Filings from KRTX instead.

View recent insider trading info

Funds Holding KRTX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding KRTX BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

39.7 Thousand total shares from 17 transactions

Exercise Derivative Conversion (M)

15 Thousand total shares from 6 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

PANDE ATUL

10,000 2021-10-01 12

MILLER ANDREW CRAIG CHIEF OPERATING OFFICER

27,827 2021-10-01 12

IGNELZI TROY A. CHIEF FINANCIAL OFFICER

597,475 2021-09-08 9

PAUL STEVEN M PRESIDENT & CEO

108,849 2021-08-17 3

HEALY JAMES

  • Director
636 2021-07-02 2

PRESTON HEATHER

  • Director
6,556 2021-06-24 3

JONAS JEFFREY M

8,500 2021-06-16 1

COUGHLIN CHRISTOPHER J

8,500 2021-06-16 1

OLSON LAURIE J

8,500 2021-06-16 2

WHEADON DAVID E.

8,500 2021-06-16 3

TORRES DENICE

8,500 2021-06-16 3

ARCH VENTURE PARTNERS IX, LLC

ARCH VENTURE PARTNERS IX, L.P.

ARCH VENTURE PARTNERS IX OVERAGE, L.P.

ARCH VENTURE FUND IX, L.P.

ARCH VENTURE FUND IX OVERAGE, L.P.

BYBEE CLINTON

CRANDELL KEITH

  • 10% Owner
No longer subject to file 2021-04-13 1

NELSEN ROBERT

  • Director
  • 10% Owner
2,918,141 2021-04-13 3

BRANNAN STEPHEN K. CHIEF MEDICAL OFFICER

  • Officer
51,350 2021-02-23 1

PURETECH HEALTH LLC

  • FORMER 10% OWNER
No longer subject to file 2021-02-09 1

HARRIGAN EDMUND

55,163 2020-08-12 0

ALEXANDRIA VENTURE INVESTMENTS, LLC

  • 10% Owner
No longer subject to file 2019-07-02 0

CHOWRIRA BHARAT M

  • Director
10,000 2019-07-01 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

MILLER ANDREW CRAIG CHIEF OPERATING OFFICER

2021-10-05 16:13:19 -0400 2021-10-04 S 3,029 $125.17 d 27,827 direct yes 2.8348 0.9672 2.8348 2 -2.4012 4

MILLER ANDREW CRAIG CHIEF OPERATING OFFICER

2021-10-05 16:13:19 -0400 2021-10-01 S 1,787 $124.17 d 39,630 direct yes 2.8348 0.9672 2.8348 2 -2.4012 4

MILLER ANDREW CRAIG CHIEF OPERATING OFFICER

2021-10-05 16:13:19 -0400 2021-10-01 S 600 $120.13 d 43,027 direct yes 2.8348 0.9672 2.8348 2 -2.4012 4

PANDE ATUL

2021-10-01 16:21:54 -0400 2021-10-01 S 2,500 $120.72 d 0 direct yes -1.3374 -5.688 0.0 1 -5.688 6

MILLER ANDREW CRAIG CHIEF OPERATING OFFICER

2021-10-05 16:13:19 -0400 2021-10-01 S 1,210 $123.09 d 41,417 direct yes 2.8348 0.9672 2.8348 2 -2.4012 4

MILLER ANDREW CRAIG CHIEF OPERATING OFFICER

2021-10-05 16:13:19 -0400 2021-10-01 S 700 $118.55 d 43,627 direct yes 2.8348 0.9672 2.8348 2 -2.4012 4

PANDE ATUL

2021-10-01 16:21:54 -0400 2021-10-01 M 2,500 $16.00 a 2,500 direct -1.3374 -5.688 0.0 1 -5.688 6

MILLER ANDREW CRAIG CHIEF OPERATING OFFICER

2021-10-05 16:13:19 -0400 2021-10-01 S 8,774 $125.18 d 30,856 direct yes 2.8348 0.9672 2.8348 2 -2.4012 4

MILLER ANDREW CRAIG CHIEF OPERATING OFFICER

2021-10-05 16:13:19 -0400 2021-10-01 S 400 $121.34 d 42,627 direct yes 2.8348 0.9672 2.8348 2 -2.4012 4

PANDE ATUL

2021-10-01 16:21:54 -0400 2021-10-01 M 2,500 d 10,000 direct

IGNELZI TROY A. CHIEF FINANCIAL OFFICER

2021-09-10 16:58:56 -0400 2021-09-10 S 1,900 $120.05 d 18,000 direct yes -2.0472 -3.8311 0.2209 5 -3.8311 6

IGNELZI TROY A. CHIEF FINANCIAL OFFICER

2021-09-10 16:58:56 -0400 2021-09-10 M 1,900 $9.20 a 19,900 direct -2.0472 -3.8311 0.2209 5 -3.8311 6

IGNELZI TROY A. CHIEF FINANCIAL OFFICER

2021-09-10 16:58:56 -0400 2021-09-10 M 1,900 d 179,725 direct

IGNELZI TROY A. CHIEF FINANCIAL OFFICER

2021-09-10 16:58:56 -0400 2021-09-09 M 500 d 181,625 direct

IGNELZI TROY A. CHIEF FINANCIAL OFFICER

2021-09-10 16:58:56 -0400 2021-09-09 M 500 $9.20 a 18,500 direct -2.0472 -3.8311 0.2209 5 -3.8311 6

IGNELZI TROY A. CHIEF FINANCIAL OFFICER

2021-09-10 16:58:56 -0400 2021-09-09 S 500 $120.05 d 18,000 direct yes -2.0472 -3.8311 0.2209 5 -3.8311 6

IGNELZI TROY A. CHIEF FINANCIAL OFFICER

2021-09-10 16:58:56 -0400 2021-09-08 S 7,000 $116.16 d 18,000 direct yes -2.0472 -3.8311 0.2209 5 -3.8311 6

IGNELZI TROY A. CHIEF FINANCIAL OFFICER

2021-09-10 16:58:56 -0400 2021-09-08 M 600 d 182,125 direct

IGNELZI TROY A. CHIEF FINANCIAL OFFICER

2021-09-10 16:58:56 -0400 2021-09-08 S 600 $121.01 d 18,000 direct yes -2.0472 -3.8311 0.2209 5 -3.8311 6

IGNELZI TROY A. CHIEF FINANCIAL OFFICER

2021-09-10 16:58:56 -0400 2021-09-08 M 7,000 $9.20 a 25,000 direct -2.0472 -3.8311 0.2209 5 -3.8311 6

IGNELZI TROY A. CHIEF FINANCIAL OFFICER

2021-09-10 16:58:56 -0400 2021-09-08 M 7,000 d 182,725 direct

IGNELZI TROY A. CHIEF FINANCIAL OFFICER

2021-09-10 16:58:56 -0400 2021-09-08 M 600 $9.20 a 18,600 direct -2.0472 -3.8311 0.2209 5 -3.8311 6

MILLER ANDREW CRAIG CHIEF OPERATING OFFICER

2021-09-03 17:50:08 -0400 2021-09-02 S 2,673 $125.51 d 44,327 direct yes -4.5536 -5.561 1.982 2.588 19 -7.2809 10

PANDE ATUL

2021-09-01 16:28:04 -0400 2021-09-01 M 2,500 $16.00 a 2,500 direct -3.0225 -4.2846 -0.5064 0.6913 21 -8.9952 12

MILLER ANDREW CRAIG CHIEF OPERATING OFFICER

2021-09-03 17:50:08 -0400 2021-09-01 S 500 $119.52 d 47,000 direct yes -4.5536 -5.561 1.982 2.588 19 -7.2809 10

PANDE ATUL

2021-09-01 16:28:04 -0400 2021-09-01 M 2,500 d 12,500 direct

MILLER ANDREW CRAIG CHIEF OPERATING OFFICER

2021-09-03 17:50:08 -0400 2021-09-01 S 3,410 $118.62 d 47,500 direct yes -4.5536 -5.561 1.982 2.588 19 -7.2809 10

PANDE ATUL

2021-09-01 16:28:04 -0400 2021-09-01 S 2,500 $117.82 d 0 direct yes -3.0225 -4.2846 -0.5064 0.6913 21 -8.9952 12

MILLER ANDREW CRAIG CHIEF OPERATING OFFICER

2021-09-03 17:50:08 -0400 2021-09-01 S 1,590 $117.87 d 50,910 direct yes -4.5536 -5.561 1.982 2.588 19 -7.2809 10

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
KARUNA THERAPEUTICS INC KRTX 2021-10-25 22:15:03 UTC -0.2073 0.2773 300000
KARUNA THERAPEUTICS INC KRTX 2021-10-25 21:45:03 UTC -0.2073 0.2773 300000
KARUNA THERAPEUTICS INC KRTX 2021-10-25 21:15:03 UTC -0.2073 0.2773 300000
KARUNA THERAPEUTICS INC KRTX 2021-10-25 20:45:03 UTC -0.2019 0.2719 300000
KARUNA THERAPEUTICS INC KRTX 2021-10-25 20:15:03 UTC -0.2019 0.2719 300000
KARUNA THERAPEUTICS INC KRTX 2021-10-25 19:45:04 UTC -0.2019 0.2719 300000
KARUNA THERAPEUTICS INC KRTX 2021-10-25 19:15:03 UTC -0.2019 0.2719 300000
KARUNA THERAPEUTICS INC KRTX 2021-10-25 18:45:02 UTC -0.1922 0.2622 300000
KARUNA THERAPEUTICS INC KRTX 2021-10-25 18:15:03 UTC -0.1922 0.2622 300000
KARUNA THERAPEUTICS INC KRTX 2021-10-25 17:45:03 UTC -0.1922 0.2622 300000
KARUNA THERAPEUTICS INC KRTX 2021-10-25 17:15:03 UTC -0.1922 0.2622 300000
KARUNA THERAPEUTICS INC KRTX 2021-10-25 16:45:02 UTC -0.2056 0.2756 300000
KARUNA THERAPEUTICS INC KRTX 2021-10-25 16:15:03 UTC -0.2056 0.2756 300000
KARUNA THERAPEUTICS INC KRTX 2021-10-25 15:45:03 UTC -0.2056 0.2756 300000
KARUNA THERAPEUTICS INC KRTX 2021-10-25 15:15:03 UTC -0.2056 0.2756 300000
KARUNA THERAPEUTICS INC KRTX 2021-10-25 14:45:02 UTC -0.1986 0.2686 300000
KARUNA THERAPEUTICS INC KRTX 2021-10-25 14:15:03 UTC -0.1986 0.2686 300000
KARUNA THERAPEUTICS INC KRTX 2021-10-25 13:45:03 UTC -0.1986 0.2686 300000
KARUNA THERAPEUTICS INC KRTX 2021-10-25 13:15:03 UTC -0.1986 0.2686 300000
KARUNA THERAPEUTICS INC KRTX 2021-10-25 12:45:04 UTC -0.1986 0.2686 300000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
FundVantage Trust- Gotham Enhanced Index Plus Fund KRTX -11.0 shares, $-792.0 2020-03-31 N-PORT
FundVantage Trust- Gotham Master Neutral Fund KRTX -6.0 shares, $-463.92 2020-09-30 N-PORT
FundVantage Trust- Gotham Index Plus All-Cap Fund KRTX -11.0 shares, $-792.0 2020-03-31 N-PORT
Trust for Professional Managers- Convergence Long/Short Equity Fund KRTX -368.0 shares, $-41149.76 2021-05-31 N-PORT

Elevate your investments